<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In the single-step impregnation and foaming process to produce microporous biopolymeric foams with encapsulated ingredients, supercritical CO
 <sub class="sub">2</sub> acts both as a solvent for the active ingredient and as a solute in infiltrating the polymer matrix. This is a promising technique where a residual solvent-free implant can be obtained at low processing temperatures, which can be particularly important for thermally-labile active ingredients [
 <xref rid="B104-pharmaceutics-11-00021" ref-type="bibr" class="xref">104</xref>]. Indomethacin [
 <xref rid="B103-pharmaceutics-11-00021" ref-type="bibr" class="xref">103</xref>] and 5-fluorouracil [
 <xref rid="B102-pharmaceutics-11-00021" ref-type="bibr" class="xref">102</xref>] have been encapsulated in microporous polymer foams using the impregnation and foaming processes.
</p>
